Echocardiography emerges as targeted tool for detecting hidden heart damage in hypertension

Arterial hypertension remains the strongest modifiable risk factor for cardiovascular disease worldwide, contributing substantially to heart failure, ischaemic heart disease, stroke, chronic kidney disease and premature mortality. Yet despite advances in drug therapy and public health campaigns, blood pressure control remains suboptimal in many populations, and cardiovascular risk often accumulates silently over years before clinical disease becomes apparent. A newly published narrative review now brings together contemporary hypertension guidelines and imaging consensus documents to clarify when echocardiography adds genuine value in detecting the cardiac consequences of high blood pressure, and when it may be an unnecessary investigation.

The review, published in Echo Research & Practice, positions transthoracic echocardiography not as a universal screening test for everyone with raised blood pressure but as a targeted investigation to detect and characterise hypertension-mediated organ damage in patients where the findings will change risk stratification or management. The authors, a multidisciplinary team of cardiologists and imaging specialists, emphasise that contemporary guidelines differ in how blood pressure is categorised and when additional investigation is recommended, and these differences influence how cardiac imaging is deployed across healthcare systems. The 2024 European Society of Cardiology guideline recommends echocardiography when there are electrocardiogram abnormalities or clinical signs suggesting left ventricular dysfunction or structural heart disease, and notes that broader use in newly diagnosed hypertension may be considered where resources allow. The 2023 European Society of Hypertension guideline adopts a tiered approach using clinical evaluation and ECG as first-line, reserving cardiac imaging for when it meaningfully reclassifies risk or influences treatment intensity. The 2025 American Heart Association and American College of Cardiology guidance places echocardiography among optional tests that may assist in detecting organ damage and refining risk stratification.

Alongside these hypertension-specific guidelines, modality-focused documents help translate recommendations into practical imaging pathways. The joint European Association of Cardiovascular Imaging and American Society of Echocardiography recommendations from 2015 emphasised that routine echocardiography in uncomplicated, asymptomatic hypertension is generally low value, while endorsing a trigger-based approach that prioritises scanning when clinical suspicion of cardiac involvement is raised. A subsequent consensus statement framed echocardiography within a broader multimodality approach, particularly in patients in whom the presence of organ damage would reclassify risk and influence treatment decisions. UK guidance from the British and Irish Hypertension Society highlights the importance of specialist evaluation in young-onset hypertension, resistant hypertension and suspected secondary causes, supporting targeted investigation rather than universal cardiac imaging. The British Society of Echocardiography triage resources provide a nationally endorsed framework to prioritise scanning where there are symptoms, an abnormal ECG, suspected structural heart disease or when results are likely to alter management.

The pathophysiology underlying these recommendations is complex. Hypertensive heart disease encompasses a spectrum of structural and functional cardiac changes resulting from chronic pressure overload, including left ventricular hypertrophy, altered ventricular geometry, diastolic dysfunction, atrial remodelling and progressive impairment of myocardial performance. However, the extent to which these findings represent a distinct disease entity attributable to blood pressure alone has been challenged, with recent commentaries arguing the term may overstate direct causality that may reflect ageing and multimorbidity. Elevated blood pressure nevertheless remains an important contributor to adverse myocardial function through chronic pressure overload, progressive arterial stiffening and impaired ventricular-arterial coupling that increases central systolic and pulsatile load. This mechanical burden drives compensatory myocardial hypertrophy accompanied by maladaptive pathways including neurohormonal activation, endothelial dysfunction, oxidative stress and inflammation that promote fibrosis, increased stiffness, impaired relaxation and reduced coronary flow reserve.

Echocardiography has been central to describing the geometric patterns of left ventricular adaptation using relative wall thickness and left ventricular mass. Contemporary guidance categorises left ventricular geometry as normal, concentric remodelling, concentric hypertrophy or eccentric hypertrophy. Echocardiographic left ventricular mass is an established independent predictor of cardiovascular events and mortality, supporting its role as a marker of cumulative blood pressure exposure. Compared with normal geometry, concentric remodelling and both hypertrophy patterns have been consistently associated with higher cardiovascular risk, with concentric and eccentric hypertrophy representing the highest-risk phenotypes. Importantly, increased wall thickness should not be assumed to be hypertensive in origin, particularly when the degree of thickening appears disproportionate to the severity or duration of blood pressure elevation. In such settings, echocardiographic red flags include reduced global longitudinal strain with relative apical sparing suggestive of cardiac amyloidosis, and very low mitral annular tissue Doppler velocities that may indicate an infiltrative or storage cardiomyopathy rather than uncomplicated hypertensive remodelling.

Strain imaging has emerged as a particularly informative technique for detecting subclinical dysfunction. Speckle-tracking echocardiography has become central to identifying early myocardial impairment, and global longitudinal strain may decline before changes in ejection fraction become apparent. A meta-analysis showed consistent impairment of strain parameters in hypertensive individuals compared with controls, supporting global longitudinal strain as a complementary marker of systolic dysfunction. However, strain should be interpreted cautiously in hypertension because it is load dependent and may worsen acutely with increased afterload even when intrinsic myocardial contractility is unchanged. Inter-vendor differences and differences in post-processing methodology persist, and there are no universally accepted hypertension-specific thresholds, meaning absolute values should be interpreted in context rather than as a standalone diagnostic cut-off. Pressure-strain analysis, which integrates contemporaneous blood pressure with strain to better reflect systolic performance under increased afterload, remains an emerging adjunct rather than a routine standard.

Diastolic function and filling pressures represent another domain where echocardiography provides the principal non-invasive framework. Current recommendations advocate an integrated approach incorporating transmitral Doppler inflow, tissue Doppler annular velocities and supportive indices such as E/e′, tricuspid regurgitation velocity and indexed left atrial volume to infer the likelihood of elevated filling pressures. However, the diagnostic performance of individual parameters is modest, and no single variable is sufficiently robust to be overinterpreted in isolation. In hypertensive cohorts, echocardiographic diastolic abnormalities have been shown to have prognostic implications, with guideline-defined diastolic dysfunction predicting major adverse cardiovascular events in a community hypertension cohort, and tissue Doppler indices predicting long-term cardiovascular mortality in legacy follow-up of a major hypertension trial. Left atrial remodelling serves as a marker of cumulative diastolic burden, and speckle-tracking-derived left atrial strain provides a quantitative measure of atrial function that may refine interpretation when conventional indices are borderline.

The review also addresses right ventricular involvement, valvular heart disease and aortic assessment. Although arterial hypertension is classically viewed as a left-sided disorder, growing evidence suggests right ventricular remodelling with hypertrophy and dysfunction can occur, most often as a downstream consequence of raised left-sided filling pressures. Large UK electronic health record cohorts have demonstrated that long-term exposure to higher blood pressure was associated with increased risk of aortic stenosis, aortic regurgitation and mitral regurgitation, supporting elevated blood pressure as a potentially modifiable risk factor for valve disease. Hypertension also alters loading conditions and therefore the echocardiographic assessment of valve lesions, with elevated blood pressure potentially reducing measured transvalvular gradients in aortic stenosis such that stenosis severity may be partially masked. The authors advocate that contemporaneous blood pressure measurement should be routine when interpreting Doppler haemodynamics and that blood pressure at the time of the study should be documented in reports.

Looking forward, the review identifies artificial intelligence-enabled quantification, prevention-focused pathways and selective multimodality imaging within specialist hypertension services as key future directions. An estimated 1.4 billion adults aged 30 to 79 years worldwide had hypertension in 2024, with only a minority having their blood pressure controlled. The global obesity crisis, with over 890 million adults living with obesity in 2022, is accelerating the incidence of hypertension and cardiometabolic disease. The authors argue that echocardiography is likely to have an expanding role in cardiovascular risk stratification by identifying cardiac structural and functional manifestations that refine risk beyond clinic blood pressure alone, but that repeat imaging should be individualised and financially sustainable. In most patients, confirming real-world blood pressure burden with ambulatory or home monitoring should be prioritised when interpreting cardiac changes, while the ECG remains the simplest scalable initial tool despite its limitations.

Subject of Research: The role of echocardiography in assessing hypertension-mediated cardiac damage

Article Title: Echocardiographic assessment in arterial hypertension: a contemporary narrative review

Article References: Naderi, H., Victor, K., Williams, L., Swift, P. A., Wilkinson, I., & Bhattacharyya, S. (2026). Echocardiographic assessment in arterial hypertension: a contemporary narrative review. Echo Research & Practice, 13(1), Article 15. https://doi.org/10.1186/s44156-026-00125-3

Image Credits: AI Generated

DOI: 10.1186/s44156-026-00125-3

Keywords: echocardiography, hypertension, left ventricular hypertrophy, global longitudinal strain, diastolic dysfunction, cardiac imaging, blood pressure, cardiovascular risk, heart failure, guidelines, speckle-tracking echocardiography, aortic regurgitation